Newsflash Asia – Breaking Stories, Smarter and Faster

[user-icon-header-short device='mobile']

Industry News


Information Technology

8×8 acquires Maven Lab to boost APAC engagement

8×8, Inc., a global leader in business communications, has announced the acquisition of Maven Lab, a Singapore-based company specialising in mobile marketing and enterprise messaging. This strategic move aims to enhance 8×8’s capabilities in delivering end-to-end customer engagement across the Asia-Pacific (APAC) region. The acquisition is set to bolster 8×8’s APAC-native messaging and automation capabilities, supporting enterprises and public-sector organisations in managing secure, high-volume communications.

Maven Lab’s integration into 8×8 will see the incorporation of Moobidesk, Maven Lab’s cloud-based customer engagement platform, into the 8×8 Platform for Customer Experience (CX). This integration promises a more scalable and unified platform, improving enterprise messaging performance and supporting a wider range of customer interaction channels. Sylvain Chaperon, General Manager, CPaaS at 8×8, stated, “Maven Lab brings deep experience delivering packaged, outcome-oriented messaging solutions that customers can deploy quickly.”

The collaboration will focus on enhancing engagement capabilities in the region, including smarter automation and support for emerging channels. Hiew Wee Soon, Co-Founder and CEO at Maven Lab, remarked, “Joining forces with 8×8 is a step-change for what our customers can do next.”

Maven Lab’s platforms are already trusted by organisations in healthcare, media, and transport, delivering millions of customer engagements annually. With 8×8’s global scale and compliance standards, customers are expected to benefit from improved data protection and security, supporting more sophisticated automation and omnichannel communication experiences across APAC.


Economy

KPMG and SID reveal Budget 2026 strategies

KPMG in Singapore and the Singapore Institute of Directors (SID) have unveiled their strategic recommendations for Singapore’s Budget 2026, focusing on enhancing the nation’s role as a global hub. The proposal, titled “Prospering in a New Global Landscape,” is informed by a survey of over 1,000 professionals and business owners, highlighting the challenges they face and the support they seek from the upcoming budget.

The recommendations are centred around three key areas. Firstly, the concept of a “new global order” emphasises resilience as a growth strategy. This includes initiatives like a unified digital platform for Free Trade Agreement management and the implementation of progressive carbon taxes to bolster economic linkages.

Secondly, the “Intelligent Age” focuses on fostering an ecosystem of Trusted AI. This involves co-funded sector-specific data pools and a regional “Trusted AI” mark to ensure ethical governance and innovation. The aim is to address accountability and ethical deployment concerns in the rapidly evolving technological landscape.

Lastly, the “Next-gen talent” strategy seeks to empower future leaders with cross-domain skills. This includes introducing a dedicated work-pass category for “master trainers” and mentors, alongside job transformation roadmaps with co-funded training. A dedicated fund is also proposed to advance social impact reporting and enhance Environmental, Social, and Governance (ESG) competencies.

These strategies are designed to position Singapore as a trusted connector and aggregator of global flows, ensuring its long-term prosperity amidst evolving global geopolitics and economic shifts. The proposal reflects a proactive approach to maintaining Singapore’s competitive edge in the global arena.


Healthcare

Fullerton Health acquires Singapore’s The ENT Clinic

Fullerton Health has announced the acquisition of The ENT Clinic, one of Singapore’s largest otolaryngology practices, as part of its strategy to enhance its speciality care capabilities. Founded by Dr Jeeve Kanagalingam in 2015, The ENT Clinic has expanded from a single doctor to a network of five specialists across three key medical hubs in Singapore: Camden, Novena, and Gleneagles Tanglin.

The acquisition is set to bolster Fullerton Health’s presence in the ENT field, a priority area due to high referral volumes and synergy with the Group’s existing services, including diagnostic imaging and primary care. “We are delighted to welcome The ENT Clinic into the Fullerton Health family,” said Margareta Laminto, Managing Director, Specialist & RadLink, and Group Chief Sustainability Officer of Fullerton Health. She highlighted the acquisition’s role in expanding clinical service capabilities and enhancing coordinated care delivery.

The ENT Clinic will continue to operate under its current brand, maintaining its trusted relationships with patients and referring physicians. Kanagalingam expressed enthusiasm about the partnership, noting, “Joining Fullerton Health marks an exciting new chapter for The ENT Clinic. We see strong synergies in partnering with a well-established healthcare organisation.”

This move allows Fullerton Health to deliver integrated, patient-centric healthcare across Southeast Asia, with The ENT Clinic benefiting from the Group’s extensive network and operational expertise. The collaboration aims to unlock new growth opportunities and expand service offerings in ENT care.


Residential Property

PropNex proposes policy changes for Singapore Budget 2026

PropNex, one of Singapore’s largest real estate agency, has reported its recommendations for the upcoming Singapore Budget 2026, focusing on market stability, housing affordability, and urban renewal. The agency suggests recalibrating policies to address challenges faced by buyers and homeowners, without compromising affordability or sustainability.

Among the key proposals is the reduction of the additional buyer’s stamp duty (ABSD) for foreigners purchasing high-value non-landed private homes in the Core Central Region (CCR). Kelvin Fong, CEO of PropNex, highlighted the resilience of the Singapore property market, stating, “The healthy home sales and moderate price growth in the past year have showcased both the resilience and discipline in the Singapore property market.”

PropNex recommends lowering the ABSD rate for foreigners to 30% for properties priced at $10m and above, aiming to stimulate sales in the ultra-luxury segment without affecting local buyers. Additionally, the agency suggests reducing the en bloc sale consent threshold to 70% for developments over 40 years old, facilitating urban renewal and optimising land use.

The agency also proposes extending the ABSD remission deadline for large-scale housing projects to seven years, providing developers more time to market units and undertake ambitious projects. Lastly, PropNex advocates raising the mortgage servicing ratio from 30% to 40% for new executive condominium buyers, reflecting rising property prices and ensuring financial prudence.

These recommendations, if adopted, could enhance market dynamics and support Singapore’s urban development goals, offering a balanced approach to property market challenges.


Information Technology

Ensign InfoSecurity ranks 7th in global MSSP list

Ensign InfoSecurity has secured the 7th position in the 2025 MSSP Alert Top 250 Managed Security Service Providers list, marking its fourth consecutive year in the global top 10. This achievement reaffirms Ensign’s status as the highest-ranked MSSP from the Asia Pacific region. The MSSP Alert Top 250 list is an annual benchmark that evaluates managed security service providers worldwide based on service breadth, capability, revenue, and innovation.

The company’s sustained recognition highlights its commitment to delivering cutting-edge managed security services amidst escalating global cyber threats. Charles Ng, CEO of Ensign InfoSecurity, stated, “The continued recognition in the MSSP Alert Top 250 highlights our unwavering commitment to delivering world-class managed security services that keep pace with the evolving threat landscape.”

In a strategic move to enhance its offerings, Ensign launched the Agentic Security Operations Centre (SOC) at GovWare 2025. This centre, the first of its kind in Asia, is powered by autonomous AI agents and integrates adaptive intelligence, regional threat insights, and human expertise. It aims to enable organisations to detect, triage, and respond to cyber threats swiftly. Chua Zong Fu, Executive Vice President of International Business at Ensign, noted, “The Agentic SOC represents a fundamental shift in how organisations defend themselves, combining adaptive AI with expert human oversight to stay ahead of adversaries.”

Ensign InfoSecurity, headquartered in Singapore, continues to lead in cybersecurity services, offering bespoke solutions across the Asia Pacific region.


Residential Property

HDB resale prices dip as transaction volumes rise

HDB resale prices in Singapore experienced a slight decline of 0.6% in December 2025, according to the latest 99-SRX Media Flash Report. Despite this dip, transaction volumes rose by 21.9% from the previous month, indicating a dynamic shift in the market. This trend is attributed to a potential alignment between buyer and seller expectations, as more than 13,000 flats are expected to reach their Minimum Occupation Period (MOP) in 2026.

The report highlights that the price decrease was observed across different room types, with 3-room, 4-room, 5-room, and Executive flats seeing reductions of 0.3%, 0.9%, 1.1%, and 0.6%, respectively. However, on a year-on-year basis, prices have increased by 2.3% compared to December 2024, with Executive flats showing the highest rise at 5.7%.

Luqman Hakim, Chief Data & Analytics Officer at 99.co, noted that the current market conditions present a timely opportunity for buyers. “December’s price moderation likely presented a timely opportunity to enter the market,” he said, as buyers acted to secure properties before potential competition increases next year.

In December, 2,040 HDB resale flats were transacted, with 55% of these coming from Non-Mature Estates. Notably, 145 flats were sold for at least S$1m, marking an increase from November’s 120 units. The highest transaction was a 5-room flat at The Peak @ Toa Payoh, sold for S$1.525m.

As the market transitions, the interplay of supply and demand is expected to stabilise, potentially leading to a more balanced and sustainable environment in 2026.


Commercial Property

Savills Singapore launches collective sale of The Centrepoint units

Savills Singapore has announced the public tender for a partial plot at The Centrepoint, located at 176A Orchard Road. The sale includes 132 leasehold strata units, comprising 66 retail and 66 residential units, under Management Corporation Strata Title Plan No. 1304. This offering presents a rare chance for investors to acquire a strategically located development on Singapore’s iconic shopping belt.

The property, with a 99-year leasehold tenure and approximately 52 years remaining, spans a site area of about 44,700 square feet. Under the 2025 Master Plan, it is zoned “Commercial” with a gross plot ratio of 5.6 and a height control of up to 10 storeys. The Singapore Land Authority has verified a development baseline of approximately 171,482 square feet, with a maximum allowable Gross Floor Area of about 250,320 square feet.

Jeremy Lake, Managing Director of Investment Sales & Capital Markets at Savills Singapore, expressed confidence in exceeding the guide price of $418m, equating to $2,709 per square foot per plot ratio. He highlighted the property’s direct link to Somerset MRT station and its prime location as key attractions for developers.

Savills has a strong track record of brokering major collective sales along Orchard Road, including Concorde Hotel & Shopping Mall and Delfi Orchard. The public tender for The Centrepoint units will open on 7 January 2026 and close on 26 February 2026 at 3pm. There are no restrictions on foreign ownership, making this an attractive opportunity for both local and international investors.


Transport & Logistics

Grab acquires Infermove to boost delivery automation

Grab Holdings Ltd, the Singapore-based ride-hailing and delivery giant, has announced the acquisition of Infermove, a Chinese AI robotics firm. This strategic move, revealed during a global meeting in December, is set to bolster Grab’s automated delivery capabilities, particularly in the last-mile segment of its logistics operations.

Infermove, founded in 2021 by Aaron Lu, specialises in autonomous driving systems and mobile manipulation robots. The company’s innovative technologies, including pavement delivery robots and personal mobility robots, are designed to navigate complex real-world environments. Infermove’s proprietary Rider Shadow System allows for the efficient collection of training data, addressing industry challenges related to data acquisition.

The acquisition is expected to significantly enhance Grab’s service reliability and profit margins amidst rising labour costs and growing demand for on-demand deliveries. Infermove will continue to operate independently under Lu’s leadership, reporting directly to Grab’s Chief Technology Officer, Suthen Thomas.

Industry analysts highlight the rapid growth of the global last-mile delivery robotics market, projected to exceed $20b by 2027. This acquisition positions Grab to leverage AI-driven automation as a competitive advantage in the delivery sector.

Grab, which went public via a SPAC merger in 2021, continues to invest in technological advancements across its services. The integration of Infermove’s solutions is anticipated to complement Grab’s existing delivery network and support its expansion efforts in Southeast Asia and beyond.


Residential Property

Brisk sales boost private home prices in Singapore

Private residential property prices in Singapore saw a 0.7% increase in Q4 2025, driven by robust sales and the landed homes segment, according to flash estimates from the Urban Redevelopment Authority (URA). In contrast, Housing & Development Board (HDB) resale flat prices remained unchanged, marking the first time since Q1 2020 that prices did not rise, amidst softer resale volumes.

The landed homes segment led the charge with a 3.5% quarter-on-quarter (QOQ) price growth, its strongest in two years, despite a decrease in transactions from 559 in Q3 to 491 in Q4. This segment’s prices have risen by 7.7% in 2025, significantly higher than the 0.9% increase in 2024, likely buoyed by lower interest rates.

Non-landed private homes, however, experienced a slight dip of 0.1% QOQ, reversing the previous quarter’s 0.8% increase. The Outside Central Region (OCR) saw the largest price increase in this category at 1.0% QOQ, whilst the Core Central Region (CCR) experienced a 3.2% decline, ending a four-quarter growth streak.

Kelvin Fong, CEO of PropNex, noted that the moderate price growth in the private housing segment contributed to a more sustainable market environment, reducing the fear of missing out and hype. He highlighted the resurgence in CCR demand, with local buyers accounting for 82.6% of non-landed new private home sales in the region in 2025.

Looking ahead, PropNex anticipates a resilient private housing market in 2026, supported by stable interest rates and a robust pipeline of new launches. Private home prices are expected to grow moderately by 3% to 4% in the coming year.


Healthcare

Esco Aster partners with Shine-On for exosome drug platform

Esco Aster, a cell and derivatives contract research, development, and manufacturing organisation (CRDMO) based in Singapore, has signed a clinical cGMP manufacturing contract with Shine-On Biomedical. The collaboration focuses on Shine-On’s innovative HLA-G targeting exosome drug delivery platform, which aims to enhance drug delivery efficiency. This partnership follows Shine-On’s sponsorship of Esco Aster in 2023 for cGMP services, which included high-yield exosome development using Esco Aster’s cell line platform.

The partnership is significant as it supports Shine-On’s Investigational New Drug (IND) submission, which was cleared by the US Food and Drug Administration (FDA) in Q1 2025. Esco Aster’s comprehensive technical reports on process, analytical, and formulation development, as well as exosome drug loading and stability studies, were crucial in this approval process.

Esco Aster is also providing technical services for exploratory exosome loading feasibility studies, as instructed by Shine-On Biomedical. Shine-On is recognised as an emerging innovator in the field of exosome-based drug delivery, and this collaboration is expected to advance their proprietary product development.

This partnership highlights the growing importance of exosome technology in drug delivery systems, potentially leading to more effective treatments. The collaboration between Esco Aster and Shine-On Biomedical could pave the way for future innovations in the pharmaceutical industry, enhancing the delivery and efficacy of therapeutic agents.


1 209 210 211 212 213 701

Join The Community


[resource-center-short]
Digital Magazine

Join The Community

NEWSFLASH

x Studio

Connect with your clients by working with our in-house brand studio, using our expertise and media reach to help you create and craft your message in video and podcast, native content and whitepapers, webinars and event formats.